| | | 67828 | | 08.04.2021 | | Roche Pharma (Schweiz) AG | | | | | | | 07.04.2026 | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Phesgo 600 mg/600 mg/10 ml | Injektionslösung | Injection solution (Pertuzumabum 600mg / 10ml, Trastuzumab 600mg / 10ml) | L01FY01 | | | 02 | Phesgo 1200 mg/600 mg/15 ml | Injektionslösung | Injection solution (Pertuzumabum 1200mg / 15ml, Trastuzumab 600mg / 15ml) | L01FY01 | |
|
|
